Last Price
335.74
Today's Change
-11.66 (3.35%)
Day's Change
335.51 - 352.37
Trading Volume
285,177
Market Cap
10 Billion
Shares Outstanding
31 Million
Avg Volume
263,304
Avg Price (50 Days)
393.66
Avg Price (200 Days)
366.09
PE Ratio
31.58
EPS
10.63
Earnings Announcement
21-Oct-2024
Previous Close
347.40
Open
348.75
Day's Range
335.51 - 352.3752
Year Range
227.21 - 459.77
Trading Volume
288,084
1 Day Change
-3.36%
5 Day Change
-5.64%
1 Month Change
-8.75%
3 Month Change
-16.31%
6 Month Change
-18.04%
Ytd Change
9.87%
1 Year Change
23.57%
3 Year Change
73.23%
5 Year Change
313.93%
10 Year Change
1108.13%
Max Change
1108.13%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.